RxDoctor Payments Data

John Bartlett, MD

Internal Medicine · Marquette, MINPI 1821090994

Payments from drug & device makers

$1,896in general payments, 2019–2025

Across 125 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$503
  • Bayer$214
  • Amgen$198
  • Pfizer$151
  • Merck$151
  • Novartis$124
  • plus $554 from 14 others

What the payments were for

  • Food & beverage$1,86999%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,896 in reported general payments places this provider in the 80th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$69,693
Medicare patients
191
Services billed
1,932

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban104$117,665
OzempicSemaglutide59$84,512
XareltoRivaroxaban42$45,874
JardianceEmpagliflozin24$36,885
FarxigaDapagliflozin Propanediol25$30,756
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$27,991
MounjaroTirzepatide27$25,245
TrulicityDulaglutide20$22,674
Bromocriptine Mesylate14$13,594
Atorvastatin Calcium768$10,957
JanuviaSitagliptin Phosphate11$10,887
MyrbetriqMirabegron12$6,508
Losartan Potassium241$3,177
Rosuvastatin Calcium176$3,081
Omeprazole237$2,578

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$151$117,665104 claims
Novo NordiskOzempic$27$84,51259 claims
Lilly USA, LLCMounjaro, Trulicity$82$47,91947 claims
Johnson & JohnsonXarelto$46$45,87442 claims
Boehringer IngelheimJardiance$69$36,88524 claims
AstraZenecaFarxiga$72$30,75625 claims
GSKTrelegy Ellipta$68$27,99123 claims
MerckJanuvia$151$10,88711 claims
AbbVieSynthroid$503$2,15840 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,567 internal medicine providers in Michigan.

Other internal medicine in Marquette

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →